{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T14:31:32Z","timestamp":1794839492505,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018601","name":"Guangdong Special Support Plan","doi-asserted-by":"publisher","award":["Guangdong Special Support Plan"],"award-info":[{"award-number":["Guangdong Special Support Plan"]}],"id":[{"id":"10.13039\/501100018601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["No.2023A04J0570"],"award-info":[{"award-number":["No.2023A04J0570"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Key Area R&D Program Key Project","award":["2023B111105006"],"award-info":[{"award-number":["2023B111105006"]}]},{"name":"Major Project of Guangzhou National Laboratory","award":["GZNL2023A03003"],"award-info":[{"award-number":["GZNL2023A03003"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82500119"],"award-info":[{"award-number":["82500119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-04903-y","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T13:14:55Z","timestamp":1769260495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Fndc5 modification optimizes the therapeutic effect of rat MSCs on sepsis-induced ALI\/ARDS via activating the PI3K\/AKT signaling pathway"],"prefix":"10.1186","volume":"17","author":[{"given":"Yuling","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"issue":"19","key":"4903_CR1","first-page":"1904","volume":"377","author":"BT Thompson","year":"2017","unstructured":"Thompson BT, Chambers RC, Liu KD. Acute respiratory distress syndrome. N Engl J Med. 2017;377(19):1904\u20135.","journal-title":"N Engl J Med"},{"issue":"23","key":"4903_CR2","first-page":"2526","volume":"307","author":"VM Ranieri","year":"2012","unstructured":"Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome the Berlin definition. Jama-J Am Med Assoc. 2012;307(23):2526\u201333.","journal-title":"Jama-J Am Med Assoc"},{"issue":"7","key":"4903_CR3","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1164\/rccm.201609-1773CP","volume":"195","author":"T Pham","year":"2017","unstructured":"Pham T, Rubenfeld GD. The epidemiology of acute respiratory distress syndrome A 50th birthday review. Am J Resp Crit Care. 2017;195(7):860\u201370.","journal-title":"Am J Resp Crit Care"},{"issue":"3","key":"4903_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/17476348.2021.1848555","volume":"15","author":"E Gorman","year":"2021","unstructured":"Gorman E, Millar J, McAuley D, O\u2019Kane C. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential. Expert Rev Respir Med. 2021;15(3):301\u201324.","journal-title":"Expert Rev Respir Med"},{"issue":"8","key":"4903_CR5","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-2600(20)30304-0","volume":"8","author":"E Fan","year":"2020","unstructured":"Fan E, Beitler JR, Brochard L, et al. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? Lancet Resp Med. 2020;8(8):816\u201321.","journal-title":"Lancet Resp Med"},{"issue":"10","key":"4903_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s13238-020-00738-2","volume":"11","author":"H Qin","year":"2020","unstructured":"Qin H, Zhao A. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics. Protein Cell. 2020;11(10):707\u201322.","journal-title":"Protein Cell"},{"key":"4903_CR7","doi-asserted-by":"crossref","unstructured":"Wilson JG, Liu K, Zhuo H et al. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir Med. 2015;3(1):24\u201332.","DOI":"10.1016\/S2213-2600(14)70291-7"},{"issue":"3","key":"4903_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1164\/rccm.201701-0107CP","volume":"196","author":"JG Laffey","year":"2017","unstructured":"Laffey JG, Matthay MA. Cell-based therapy for acute respiratory distress syndrome biology and potential therapeutic value. Am J Resp Crit Care. 2017;196(3):266\u201373.","journal-title":"Am J Resp Crit Care"},{"issue":"3","key":"4903_CR9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s12015-020-09973-w","volume":"16","author":"A Golchin","year":"2020","unstructured":"Golchin A, Seyedjafari E, Ardeshirylajimi A. Mesenchymal stem cell therapy for COVID-19: present or future. Stem Cell Rev Rep. 2020;16(3):427\u201333.","journal-title":"Stem Cell Rev Rep"},{"issue":"3","key":"4903_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1164\/rccm.201705-1006OC","volume":"197","author":"LA McIntyre","year":"2018","unstructured":"McIntyre LA, Stewart DJ, Mei SHJ, et al. Cellular immunotherapy for septic shock A phase I clinical trial. Am J Resp Crit Care. 2018;197(3):337\u201347.","journal-title":"Am J Resp Crit Care"},{"issue":"2","key":"4903_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","volume":"7","author":"MA Matthay","year":"2019","unstructured":"Matthay MA, Calfee CS, Zhuo HJ, et al. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. Lancet Resp Med. 2019;7(2):154\u201362.","journal-title":"Lancet Resp Med"},{"issue":"10","key":"4903_CR12","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1016\/j.ymthe.2024.08.003","volume":"32","author":"C Tunstead","year":"2024","unstructured":"Tunstead C, Volkova E, Dunbar H, et al. The ARDS microenvironment enhances MSC-induced repair via VEGF in experimental acute lung inflammation. Mol Ther. 2024;32(10):3422\u201332.","journal-title":"Mol Ther"},{"key":"4903_CR13","doi-asserted-by":"crossref","unstructured":"Zineldeen DH, Mushtaq M, Haider KH. Cellular preconditioning and mesenchymal stem cell ferroptosis. World J Stem Cells. 2024;16(2):64\u201369.","DOI":"10.4252\/wjsc.v16.i2.64"},{"issue":"7382","key":"4903_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature10777","volume":"481","author":"P Bostr\u00f6m","year":"2012","unstructured":"Bostr\u00f6m P, Wu J, Jedrychowski MP, et al. A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463\u2013U472.","journal-title":"Nature"},{"issue":"5","key":"4903_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cmet.2013.09.008","volume":"18","author":"CD Wrann","year":"2013","unstructured":"Wrann CD, White JP, Salogiannnis J, et al. Exercise induces hippocampal BDNF through a PGC-1\u03b1\/FNDC5 pathway. Cell Metab. 2013;18(5):649\u201359.","journal-title":"Cell Metab"},{"key":"4903_CR16","doi-asserted-by":"crossref","unstructured":"Wei H, Liu SY, Wang TT et al. FNDC5 inhibits autophagy of bone marrow mesenchymal stem cells and promotes their survival after transplantation by downregulating Sp1. Cell Death Discov. 2023;9(1):336.","DOI":"10.1038\/s41420-023-01634-4"},{"key":"4903_CR17","doi-asserted-by":"crossref","unstructured":"Luo YL, Ge SH, Chen QG, Lin S, He WM, Zeng M. Overexpression of FoxM1 optimizes the therapeutic effect of bone marrow mesenchymal stem cells on acute respiratory distress syndrome. Stem Cell Res Ther. 2023;14(1):27.","DOI":"10.1186\/s13287-023-03240-8"},{"key":"4903_CR18","doi-asserted-by":"crossref","unstructured":"Faller S, Hausler F, Goeft A et al. Hydrogen sulfide limits neutrophil transmigration, inflammation, and oxidative burst in lipopolysaccharide-induced acute lung injury. Sci Rep. 2018;8(1):14676.","DOI":"10.1038\/s41598-018-33101-x"},{"issue":"6","key":"4903_CR19","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jcyt.2013.02.006","volume":"15","author":"P Bourin","year":"2013","unstructured":"Bourin P, Bunnell BA, Casteilla L, et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal\/stem cells: a joint statement of the international federation for adipose therapeutics and science (IFATS) and the international society for cellular therapy (ISCT). Cytotherapy. 2013;15(6):641\u20138.","journal-title":"Cytotherapy"},{"issue":"6","key":"4903_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10787-016-0286-z","volume":"24","author":"N Tyagi","year":"2016","unstructured":"Tyagi N, Dash D, Singh R. Curcumin inhibits Paraquat induced lung inflammation and fibrosis by extracellular matrix modifications in mouse model. Inflammopharmacology. 2016;24(6):335\u201345.","journal-title":"Inflammopharmacology"},{"key":"4903_CR21","doi-asserted-by":"crossref","unstructured":"Wang K, Wang YY, Cao YF et al. Lumican is elevated in the lung in human and experimental acute respiratory distress syndrome and promotes early fibrotic responses to lung injury. J Transl Med. 2022;20(1):392.","DOI":"10.1186\/s12967-022-03597-z"},{"issue":"4\u20136","key":"4903_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.vph.2008.06.009","volume":"49","author":"NA Maniatis","year":"2008","unstructured":"Maniatis NA, Kotanidou A, Catravas JD, Orfanos SE. Endothelial pathomechanisms in acute lung injury. Vascul Pharmacol. 2008;49(4\u20136):119\u201333.","journal-title":"Vascul Pharmacol"},{"key":"4903_CR23","doi-asserted-by":"crossref","unstructured":"Liu JQ, Xiao Q, Xiao JN et al. Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Tar. 2022;7(1):3.","DOI":"10.1038\/s41392-021-00762-6"},{"key":"4903_CR24","doi-asserted-by":"crossref","unstructured":"Bian W, Xiao SQ, Yang L, Chen J, Deng SF. Quercetin promotes bone marrow mesenchymal stem cell proliferation and osteogenic differentiation through the H19\/miR-625-5p axis to activate the Wnt\/\u03b2-catenin pathway. Bmc Complement Med. 2021;21(1):243.","DOI":"10.1186\/s12906-021-03418-8"},{"issue":"10","key":"4903_CR25","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/abbs\/gmaa091","volume":"52","author":"ZD Wang","year":"2020","unstructured":"Wang ZD, Zhang GL, Le YY, et al. Quercetin promotes human epidermal stem cell proliferation through the Estrogen receptor\/\u03b2-catenin\/c-Myc\/cyclin A2 signaling pathway. Acta Bioch Bioph Sin. 2020;52(10):1102\u201310.","journal-title":"Acta Bioch Bioph Sin"},{"issue":"1","key":"4903_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12931-018-0729-8","volume":"19","author":"J Lv","year":"2018","unstructured":"Lv J, Zeng J, Guo F, et al. Endothelial Cdc42 deficiency impairs endothelial regeneration and vascular repair after inflammatory vascular injury. Respir Res. 2018;19(1):27.","journal-title":"Respir Res"},{"key":"4903_CR27","doi-asserted-by":"publisher","first-page":"109868","DOI":"10.1016\/j.biopha.2020.109868","volume":"125","author":"Y Wu","year":"2020","unstructured":"Wu Y, Wang Y, Gong S, et al. Ruscogenin alleviates LPS-induced pulmonary endothelial cell apoptosis by suppressing TLR4 signaling. Biomed Pharmacother. 2020;125:109868.","journal-title":"Biomed Pharmacother"},{"issue":"88","key":"4903_CR28","doi-asserted-by":"publisher","first-page":"88ps25","DOI":"10.1126\/scitranslmed.3002011","volume":"3","author":"NM Goldenberg","year":"2011","unstructured":"Goldenberg NM, Steinberg BE, Slutsky AS, Lee WL. Broken barriers: a new take on sepsis pathogenesis. Sci Transl Med. 2011;3(88):88ps25.","journal-title":"Sci Transl Med"},{"issue":"335","key":"4903_CR29","doi-asserted-by":"publisher","first-page":"335ra355","DOI":"10.1126\/scitranslmed.aad9260","volume":"8","author":"S Han","year":"2016","unstructured":"Han S, Lee SJ, Kim KE, et al. Amelioration of sepsis by TIE2 activation-induced vascular protection. Sci Transl Med. 2016;8(335):335ra355.","journal-title":"Sci Transl Med"},{"issue":"11","key":"4903_CR30","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1161\/CIRCULATIONAHA.115.020918","volume":"133","author":"X Huang","year":"2016","unstructured":"Huang X, Dai Z, Cai L, et al. Endothelial p110gammaPI3K mediates endothelial regeneration and vascular repair after inflammatory vascular injury. Circulation. 2016;133(11):1093\u2013103.","journal-title":"Circulation"},{"issue":"7","key":"4903_CR31","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1164\/rccm.202311-2046CP","volume":"209","author":"GF Curley","year":"2024","unstructured":"Curley GF, O\u2019Kane CM, McAuley DF, Matthay MA, Laffey JG. Cell-based therapies for acute respiratory distress syndrome where are we now? Am J Resp Crit Care. 2024;209(7):789\u201397.","journal-title":"Am J Resp Crit Care"},{"issue":"1","key":"4903_CR32","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","volume":"7","author":"DM Hoang","year":"2022","unstructured":"Hoang DM, Pham PT, Bach TQ, et al. Stem cell-based therapy for human diseases. Signal Transduct Target Ther. 2022;7(1):272.","journal-title":"Signal Transduct Target Ther"},{"key":"4903_CR33","doi-asserted-by":"crossref","unstructured":"Zhang XR, Wei XX, Deng YW et al. Mesenchymal stromal cells alleviate acute respiratory distress syndrome through the cholinergic anti-inflammatory pathway. Signal Transduct Tar. 2022;7(1):307.","DOI":"10.1038\/s41392-022-01124-6"},{"issue":"1","key":"4903_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13287-019-1224-y","volume":"10","author":"NC Noronha","year":"2019","unstructured":"Noronha NC, Mizukami A, Caliari-Oliveira C, et al. Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies. Stem Cell Res Ther. 2019;10(1):131.","journal-title":"Stem Cell Res Ther"},{"issue":"11","key":"4903_CR35","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.4252\/wjsc.v13.i11.1625","volume":"13","author":"SY Zhang","year":"2021","unstructured":"Zhang SY, Ren JY, Yang B. Priming strategies for controlling stem cell fate: applications and challenges in dental tissue regeneration. World J Stem Cells. 2021;13(11):1625\u201346.","journal-title":"World J Stem Cells"},{"key":"4903_CR36","doi-asserted-by":"crossref","unstructured":"Hezam K, Wang C, Fu EZ et al. Superior protective effects of PGE2 priming mesenchymal stem cells against LPS-induced acute lung injury (ALI) through macrophage Immunomodulation. Stem Cell Res Ther. 2023;14(1):48.","DOI":"10.1186\/s13287-023-03277-9"},{"issue":"2","key":"4903_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.21037\/atm-21-6868","volume":"10","author":"H Wei","year":"2022","unstructured":"Wei H, Liu K, Wang T, Li Y, Guo S, Li L. FNDC5 overexpression promotes the survival rate of bone marrow mesenchymal stem cells after transplantation in a rat cerebral infarction model. Ann Transl Med. 2022;10(2):90.","journal-title":"Ann Transl Med"},{"key":"4903_CR38","doi-asserted-by":"crossref","unstructured":"Rabiee F, Lachinani L, Ghaedi S, Nasr-Esfahani MH, Megraw TL, Ghaedi K. New insights into the cellular activities of Fndc5\/Irisin and its signaling pathways. Cell Biosci. 2020;10(1):51.","DOI":"10.1186\/s13578-020-00413-3"},{"issue":"43","key":"4903_CR39","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1093\/eurheartj\/ehac431","volume":"43","author":"C Chi","year":"2022","unstructured":"Chi C, Fu H, Li YH, et al. Exerkine fibronectin type-III domain-containing protein 5\/irisin-enriched extracellular vesicles delay vascular ageing by increasing SIRT6 stability. Eur Heart J. 2022;43(43):4579\u201395.","journal-title":"Eur Heart J"},{"key":"4903_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.phrs.2018.01.012","volume":"129","author":"H Askari","year":"2018","unstructured":"Askari H, Rajani SF, Poorebrahim M, Haghi-Aminjan H, Raeis-Abdollahi E, Abdollahi M. A glance at the therapeutic potential of Irisin against diseases involving inflammation, oxidative stress, and apoptosis: an introductory review. Pharmacol Res. 2018;129:44\u201355.","journal-title":"Pharmacol Res"},{"issue":"1","key":"4903_CR41","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s13287-020-01746-z","volume":"11","author":"J Deng","year":"2020","unstructured":"Deng J, Zhang N, Wang Y, et al. FNDC5\/irisin improves the therapeutic efficacy of bone marrow-derived mesenchymal stem cells for myocardial infarction. Stem Cell Res Ther. 2020;11(1):228.","journal-title":"Stem Cell Res Ther"},{"key":"4903_CR42","doi-asserted-by":"crossref","unstructured":"Pang SHM, D\u2019Rozario J, Mendonca S et al. Mesenchymal stromal cell apoptosis is required for their therapeutic function. Nat Commun. 2021;12(1):6495.","DOI":"10.1038\/s41467-021-26834-3"},{"issue":"9","key":"4903_CR43","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.7150\/thno.96174","volume":"14","author":"MJ Li","year":"2024","unstructured":"Li MJ, Tang Q, Liao CC, et al. Extracellular vesicles from apoptotic BMSCs ameliorate osteoporosis via transporting regenerative signals. Theranostics. 2024;14(9):3583\u2013602.","journal-title":"Theranostics"},{"issue":"4","key":"4903_CR44","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/19336918.2015.1016686","volume":"9","author":"W Xu","year":"2015","unstructured":"Xu W, Yang Z, Lu N. A new role for the PI3K\/Akt signaling pathway in the epithelial-mesenchymal transition. Cell Adh Migr. 2015;9(4):317\u201324.","journal-title":"Cell Adh Migr"},{"key":"4903_CR45","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1017\/S1462399411002109","volume":"14","author":"SM Schultze","year":"2012","unstructured":"Schultze SM, Hemmings BA, Niessen M, Tschopp O. PI3K\/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis. Expert Rev Mol Med. 2012;14:e1.","journal-title":"Expert Rev Mol Med"},{"key":"4903_CR46","doi-asserted-by":"crossref","unstructured":"Sun XX, Xiang HX, Liu Z et al. Jingfang granules (\u8346\u9632\u9897\u7c92) alleviates bleomycin-induced acute lung injury through regulating PI3K\/Akt\/mTOR signaling pathway. J Ethnopharmacol. 2024;318:116946.","DOI":"10.1016\/j.jep.2023.116946"},{"key":"4903_CR47","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.2147\/JIR.S309457","volume":"14","author":"H Chen","year":"2021","unstructured":"Chen H, Li N, Zhan X, et al. Capsaicin protects against Lipopolysaccharide-Induced acute lung injury through the HMGB1\/NF-\u03baB and PI3K\/AKT\/mTOR pathways. J Inflamm Res. 2021;14:5291\u2013304.","journal-title":"J Inflamm Res"},{"key":"4903_CR48","doi-asserted-by":"crossref","unstructured":"Zhang LS, Ge SH, He WM, Chen QG, Xu CX, Zeng M. Ghrelin protects against lipopolysaccharide-induced acute respiratory distress syndrome through the PI3K\/AKT pathway. J Biol Chem. 2021;297(3):101111.","DOI":"10.1016\/j.jbc.2021.101111"},{"issue":"12","key":"4903_CR49","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1111\/1440-1681.13382","volume":"47","author":"X Wang","year":"2020","unstructured":"Wang X, Liang G, Guo Q, et al. ELABELA improves endothelial cell function via the ELA-APJ axis by activating the PI3K\/Akt signalling pathway in HUVECs and EA.hy926 cells. Clin Exp Pharmacol Physiol. 2020;47(12):1953\u201364.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"4903_CR50","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/FJC.0000000000000386","volume":"68","author":"G Zhu","year":"2016","unstructured":"Zhu G, Wang J, Song M, et al. Irisin increased the number and improved the function of endothelial progenitor cells in diabetes mellitus mice. J Cardiovasc Pharmacol. 2016;68(1):67\u201373.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"4903_CR51","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.cell.2019.06.028","volume":"178","author":"H Kim","year":"2019","unstructured":"Kim H, Wrann CD, Jedrychowski M, et al. Irisin mediates effects on bone and fat via \u03b1V integrin receptors (175, Pg 1756, 2018). Cell. 2019;178(2):507\u20138.","journal-title":"Cell"},{"key":"4903_CR52","doi-asserted-by":"crossref","unstructured":"Bi JB, Zhang J, Ren YF et al. Exercise hormone Irisin mitigates endothelial barrier dysfunction and microvascular leakage-related diseases. Jci Insight. 2020;5(13):e136277.","DOI":"10.1172\/jci.insight.136277"},{"key":"4903_CR53","doi-asserted-by":"crossref","unstructured":"Jin XH, Wu XY, Li ZH et al. Integrin \u03b1V\u03b23 mediates porcine deltacoronavirus infection and inflammatory response through activation of the FAK-PI3K-AKT-nf-\u03baB signalling pathway. Virulence. 2024;15(1):2407847.","DOI":"10.1080\/21505594.2024.2407847"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-04903-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-04903-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-04903-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:00:38Z","timestamp":1773147638000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-04903-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4903"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-04903-y","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"(1) Title of the approved project: Fndc5 modification optimizes the therapeutic effect of bone marrow mesenchymal stem cells on acute respiratory distress syndrome; (2) Name of the institutional approval committee or unit: ICE for Clinical Research and Animal Trials of The First Affiliated Hospital of Guangzhou Medical University; (3) Approval number: 20240610; (4) Date of approval: 17 July 2024.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}